Skip to main content

Table 2 Signaling and metabolic pathways enriched by genes that change expression intensity after simvastatin, FPP, and GGPP treatment of MiaPaCa-2 human pancreatic cancer cells

From: Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells

KEGG Path ID

Path name

Simva

FPP

Simva + FPP

GGPP

Simva + GGPP

hsa03030

DNA replication

+

+

+

+

hsa04110

Cell cycle

+

+

+

+

hsa03430

Mismatch repair

+

+

hsa00100

Steroid biosynthesis

+

hsa03440

Homologous recombination

+

hsa04010

MAPK signaling pathway

+

hsa00240

Pyrimidine metabolism

+

hsa00190

Oxidative phosphorylation

(−)

+

+

+

  1. Gene set enrichment analysis (GSEA) performed on KEGG signaling and metabolic pathways reveals the pathways enriched for genes that are differentially transcribed after simvastatin (12 μM) treatment, and the modulatory effects of FPP (17 μM) and GGPP (17 μM)
  2. + GSEA FDR < 0.001; − GSEA FDR > 0.001; (−) oxidative phosphorylation was only marginally significant in GSEA analysis by Tian with FDR < 0.05
  3. Simva simvastatin, FPP farnesyl pyrophosphate, GGPP geranylgeranyl pyrophosphate, FDR false discovery rate